Here are relevant reports on : automotive-diagnostics-market
-
Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024
The Lymphedema Diagnostics Market is expected to grow from USD 24 million in 2019 to USD 35 million by 2024, at a CAGR of 7.4% during the forecast period. The major players operating in the lymphedema diagnostics market are GE Healthcare (US), Philips (Netherlands), and Siemens Healthineers (Germany). Other prominent players in this market include Canon, Inc. (Japan), Shimadzu Corporation (Japan), Stryker Corporation (US), Fluoptics (France), United Imaging Healthcare Co., Ltd. (China), Hitachi, Ltd. (Japan), Esaote, SpA (Italy), Neusoft Corporation (China), Mindray Medical International, Ltd. (China), Mitaka USA, Inc. (US), Curadel, LLC (US), and ImpediMed Ltd. (Australia).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
DNA Diagnostics Market by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Global Forecast to 2029
The global DNA diagnostics market, valued at US$12.3 billion in 2023, stood at US$13.3 billion in 2024 and is projected to advance at a resilient CAGR of 9.7% from 2024 to 2029, culminating in a forecasted valuation of US$21.2 billion by the end of the period. Growth in the market is primarily driven by the technological improvements in the DNA diagnostics industry and the growing need for personalized treatment and early disease diagnosis in developing nations. Also, the increased investments by healthcare-based companies are majorly contributing to growth of the market.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Employee Transport Fleet Management Market by Solution (Operations Management, Vehicle Maintenance & Diagnostics, Performance Management, Compliance Management) & Fleet Type (Fixed-route, First- & Last-mile, Campus) - Global Forecast to 2030
The employee fleet management market is projected to reach USD 9.25 billion by 2030 from USD 4.85 billion in 2025, at a CAGR of 13.8% from 2025 to 2030. The key players include Samsara (US), Geotab (Canada), Verizon Connect (US), Teletrac Navman (US), MiX Telematics (South Africa), Motive (US), TransLoc (US), Via (US), Omnitracs (US), Webfleet (Netherlands), Azuga (US), Ridecell (US), Fleetio (US), Zonar Systems (US), and Trimble (US)
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Companion Diagnostics Market by Product (Assays, Kits, & Reagents, Instruments, Software), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Lung, Colorectal Cancer, CVD, Infectious), Drug Class (MAB, Cell & Gene Therapy) - Global Forecast to 2031
The global companion diagnostics market is projected to reach USD 11.57 billion by 2031, growing at a CAGR of 12.9% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Europe Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, mRNA), Application (Diagnostics, Personalized Medicine), End User (CROs) - Forecast to 2030
The Europe nucleic acid isolation and purification market, valued at USD1.52 billion in 2024, stood at USD1.61 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of USD2.41 billion by the end of the period. The growth of the Europe nucleic acid isolation and purification market is strongly linked to the region’s high volume of molecular tests and the steady adoption of PCR- and NGS-based workflows.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
In Vitro Diagnostics (IVD) Quality Control Market by Product & Service (QC (Plasma, Serum, Blood), Solutions), Technology (Immunoassay, MDx, Microbiology, Hematology), Manufacturer (Third-party, OEM), End User (Hospitals, Labs) - Global Forecast to 2030
The global IVD quality controls market, valued at US$1.58 billion in 2024, stood at US$1.65 billion in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2025 to 2030, culminating in a forecasted valuation of US$2.15 billion by the end of the period. The IVD quality controls market is witnessing substantial growth, driven by several key factors.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Laboratory Centrifuges Market by Product [Equipment (Microcentrifuge, Ultracentrifuge), Accessories (Tube, Plate)], Platform (Benchtop), Rotor Design (Swinging-bucket), Intended Use (Clinical), Application (Diagnostics), End User (Hospitals) - Global Forecast to 2030
The global laboratory centrifuges market, valued at US$1.53 billion in 2024, stood at US$1.58 billion in 2025 and is projected to advance at a resilient CAGR of 2.8% from 2024 to 2030, culminating in a forecasted valuation of US$1.86 billion by the end of the period. This growth is driven by increased R&D investments and research grants, technological advancements and innovative rotor designs, a rise in infectious diseases that boosts sample testing and cell-based research, and expanding applications of these centrifuges.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Cognitive Assessment and Training in Healthcare Market by Assessment Type (Pen-and-Paper Based, Hosted, and Biometrics), Components, Application (Clinical Trial, Screening & Diagnostics, Brain Training, Academic Research), & Region - Global forecast to 2021
Cognitive impairment can occur in early childhood or late adulthood. There are various reasons for it, which can be reversible or irreversible. Early causes may include malnutrition, prenatal drug exposure, genetic syndromes, and chromosome abnormalities. The brain retains its neuroplasticity till late adulthood; therefore, there has been a growing demand for cognitive assessment and training. MarketsandMarkets predicts the global cognitive assessment and training in healthcare market to grow from USD 962.0 Million in 2016 to USD 4,127.2 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 33.8%. The year 2015 has been considered as the base year, while the forecast period is 2016–2021.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
Liquid Handling System Market by Product (Pipette, Workstation, Software), Type (Automated, Electronic), Application (Drug Discovery, NGS, PCR, Diagnostics, Proteomics, Forensics), End User (Labs, Academia, F&B, Pharma-biopharma) – Global Forecast to 2031
The global liquid handling systems market is projected to reach USD 7.79 billion by 2031, growing at a CAGR of 8.2% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Cystatin C Assay Market by Product (Analyzers, Kits, Reagents), Method (ELISA, PETIA, IFA, CLIA, PENIA), Application (Diagnostics, Research), Sample Type (Blood, Urine), End User (Hospitals, Clinical Laboratories) & Region - Global Forecast to 2028
The global cystatin C assay market, valued at US$352 million in 2022, stood at US$377 million in 2023 and is projected to advance at a resilient CAGR of 7.5% from 2023 to 2028, culminating in a forecasted valuation of US$540 million by the end of the period.The growth of this market is majorly driven by the Increasing adoption of POC testing and presence of supportive government policies. However, raising awareness among healthcare providers about the benefits of cystatin C testing can be challenging.
- Published: October 2023
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
